| 26.70 Delayed Data As of 2:29pm ET |  +0.29 / +1.10%Today’s Change | 16.56 Today|||52-Week Range 29.44 | +36.64% Year-to-Date |
| Horizon (HZNP) Up 36.7% YTD: Pipeline Development in Focus Sep 12 / Zacks.com - Paid Partner Content | Horizon's (HZNP) Eye Disease Drug Gets FDA's Priority Review Sep 10 / Zacks.com - Paid Partner Content |
| Biotech Stock Roundup: AMGN's Lung Cancer Candidate, ALXN's Deal With Eidos in Focus Sep 11 / Zacks.com - Paid Partner Content | Why Is Horizon Therapeutics (HZNP) Down 3.3% Since Last Earnings Report? Sep 06 / Zacks.com - Paid Partner Content |
